BMY vs ENTX · P/E 17, rev $24.46B vs $58.2M cap
Bristol-Myers Squibb Company (BMY) versus Entera Bio Ltd (ENTX) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Entera Bio Ltd (ENTX) is a biotechnology company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported ENTX revenue for 2026-06-30 was $0. Net income was -$10.8M. ENTX currently screens at market cap $58.2M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. ENTX currently screens at market cap $58.2M.
Not investment advice. Open the BMY and ENTX stock pages for the full models.
Not investment advice.